KELLY SEALS: Open Payments
NPI 1063855757 · FREDERICKSBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,170 in 61 payments from 11 companies in 2025. Trend: 2023 $983 · 2024 $1,029 · 2025 $1,170
Food & beverage: $1,170
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $299 |
| Aimmune Therapeutics, Inc. | 10 | $176 |
| Madrigal Pharmaceuticals | 7 | $151 |
| PFIZER INC. | 8 | $148 |
| Ipsen Biopharmaceuticals, Inc | 5 | $118 |
| GENZYME CORPORATION | 4 | $109 |
| Gilead Sciences, Inc. | 3 | $64 |
| Janssen Biotech, Inc. | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Ardelyx, Inc. | 1 | $19 |
Products named: ZENPEP, REZDIFFRA, VELSIPITY, DUPIXENT, MAVYRET, IQIRVO, CREON, TREMFYA.
Industry payments across TX — which companies pay providers there.
